Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Veerman

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 1996
Synergistic interaction between cisplatin and gemcitabine in vitroA M Bergman, V W Ruiz van Haperen, G Veerman, et al.
European Journal of Cancer (Oxford, England : 1990)|November 3, 1998
Augmentation of 1-beta-D-arabinofuranosylcytosine (Ara-C) cytotoxicity in leukaemia cells by co-administration with antisignalling drugsA Freund, J Boos, S Harkin, et al.
Advances in Experimental Medicine and Biology|January 1, 1994
Synergistic interaction between cisplatin and gemcitabine in ovarian and colon cancer cell linesA M Bergman, V W Ruiz van Haperen, G Veerman, et al.
European Journal of Cancer (Oxford, England : 1990)|November 3, 1998
Postconfluent multilayered cell line cultures for selective screening of gemcitabineE Smitskamp-Wilms, H M Pinedo, G Veerman, et al.
Biochemical Pharmacology|October 7, 1994
Schedule dependence of sensitivity to 2',2'-difluorodeoxycytidine (Gemcitabine) in relation to accumulation and retention of its triphosphate in solid tumour cell lines and solid tumoursV W Ruiz van Haperen, G Veerman, E Boven, et al.
In Vivo (Athens, Greece)|January 1, 1995
In vitro antiproliferative effects, toxicity profiles in vivo in mice and antitumour activity in tumour-bearing mice of five organotin compoundsM Gielen, R Willem, A Bouhdid, et al.
Seminars in Oncology|August 1, 1995
Interaction between cisplatin and gemcitabine in vitro and in vivoG J Peters, A M Bergman, V W Ruiz van Haperen, et al.
Advances in Experimental Medicine and Biology|May 23, 1998
Cross-resistance of the gemcitabine resistant human ovarian cancer cell line AG6000 to standard and investigational drugsA M Bergman, H M Pinedo, V W Ruiz van Haperen, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Deoxycytidine kinase and deoxycytidine deaminase activities in human tumour xenograftsV W Ruiz van Haperen, G Veerman, B J Braakhuis, et al.
Seminars in Oncology|April 1, 1997
Combination chemotherapy studies with gemcitabineC J van Moorsel, G Veerman, A M Bergman, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 1996
Synergistic interaction between cisplatin and gemcitabine in vitroA M Bergman, V W Ruiz van Haperen, G Veerman, et al.
European Journal of Cancer (Oxford, England : 1990)|November 3, 1998
Augmentation of 1-beta-D-arabinofuranosylcytosine (Ara-C) cytotoxicity in leukaemia cells by co-administration with antisignalling drugsA Freund, J Boos, S Harkin, et al.
Advances in Experimental Medicine and Biology|January 1, 1994
Synergistic interaction between cisplatin and gemcitabine in ovarian and colon cancer cell linesA M Bergman, V W Ruiz van Haperen, G Veerman, et al.
European Journal of Cancer (Oxford, England : 1990)|November 3, 1998
Postconfluent multilayered cell line cultures for selective screening of gemcitabineE Smitskamp-Wilms, H M Pinedo, G Veerman, et al.
Biochemical Pharmacology|October 7, 1994
Schedule dependence of sensitivity to 2',2'-difluorodeoxycytidine (Gemcitabine) in relation to accumulation and retention of its triphosphate in solid tumour cell lines and solid tumoursV W Ruiz van Haperen, G Veerman, E Boven, et al.
In Vivo (Athens, Greece)|January 1, 1995
In vitro antiproliferative effects, toxicity profiles in vivo in mice and antitumour activity in tumour-bearing mice of five organotin compoundsM Gielen, R Willem, A Bouhdid, et al.
Seminars in Oncology|August 1, 1995
Interaction between cisplatin and gemcitabine in vitro and in vivoG J Peters, A M Bergman, V W Ruiz van Haperen, et al.
Advances in Experimental Medicine and Biology|May 23, 1998
Cross-resistance of the gemcitabine resistant human ovarian cancer cell line AG6000 to standard and investigational drugsA M Bergman, H M Pinedo, V W Ruiz van Haperen, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Deoxycytidine kinase and deoxycytidine deaminase activities in human tumour xenograftsV W Ruiz van Haperen, G Veerman, B J Braakhuis, et al.
Seminars in Oncology|April 1, 1997
Combination chemotherapy studies with gemcitabineC J van Moorsel, G Veerman, A M Bergman, et al.
Pageof 4